Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353560 · ClinicalTrials.gov registry record
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study 1-Survey
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 1,509
- Enrollment target
NCT01353560: Completed study, sponsored by Brigham and Women's Hospital.
NCT01353560 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01353560 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 1,509 participants
- Enrollment target
Study Summary
Despite widespread and growing popularity of complementary and alternative medicine (CAM) in the US, there currently exist significant gaps in our knowledge regarding CAM use, clinical effectiveness, safety and cost- effectiveness. With previous funding support from NCCAM, the Harvard Medical School (HMS) Osher Research Center established and trained a multidisciplinary integrative team of CAM and conventional providers to work collaboratively to provide state-of-the-art "integrative care" in a coordinated and individualized fashion. The Osher Integrative Care Center (OCC) was opened in fall 2007, physically located within the Ambulatory Care Center of the Brigham and Women's Hospital (BWH) at 850 Boylston Street in Chestnut Hill, MA. The focus of this survey study is to characterize the decision-making process of both patients and conventional providers with respect to communication about and referral to an integrative care team in an academic hospital outpatient setting.
Primary Outcome
Surveys will be sent to: 1) 1500 consecutive new patients seen at the OCC over 3.5 years, to characterize the chief complaints; their medical history; referral sources; communication with their physicians; barriers to use of CAM; views regarding and previous use of CAM; and expectations for CAM therapy as adjuncts to their conventional care; 2) 300 BWH physicians from five divisions (Women's Health, Orthopedics, Obstetrics and Gynecology, General Medicine, and Rheumatology) most likely to refer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,509 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-10 |
What the finished NCT01353560 record still lists
NCT01353560 is an observational study that tracks outcomes without assigning an intervention. Its 1,509 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01353560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01353560 about?
NCT01353560 is a clinical study titled "Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study 1-Survey". Despite widespread and growing popularity of complementary and alternative medicine (CAM) in the US, there currently exist significant gaps in our knowledge regarding CAM use, clinical effectiveness, safety and cost- effectiveness. With previous funding support from NCCAM, the Harvard Medical School...
What is the current status of trial NCT01353560?
This trial is currently completed. The enrollment target is 1,509 participants. The study started on 2011-05. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT01353560?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia